Related Experiment Video

Updated: Apr 17, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.8K

Antibacterial mechanisms of polymyxin and bacterial resistance

Zhiliang Yu1, Wangrong Qin1, Jianxun Lin2

  • 1College of Biological and Environmental Engineering, Zhejiang University of Technology, Hangzhou 310014, China.

Biomed Research International
|February 10, 2015
PubMed

Insights

Multidrug-resistant pathogens pose a severe threat, with polymyxins as a last resort antibiotic. This review explores polymyxin mechanisms, resistance, and modifications to guide future therapies and minimize resistance development.

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Multidrug resistance (MDR) in bacterial pathogens is a critical global health concern.
  • Limited antibiotic options necessitate exploring last-resort drugs like polymyxins.
  • Polymyxin use is associated with the emergence of resistant strains, demanding further research.

Purpose of the Study:

  • To review recent advances in understanding polymyxin's antibacterial mechanisms.
  • To discuss bacterial tolerance mechanisms against polymyxins.
  • To summarize polymyxin structure, synthesis, and potential for structural modification.

Main Methods:

  • Literature review of scientific articles on polymyxins and antimicrobial resistance.
  • Analysis of studies detailing polymyxin antibacterial activity and resistance.
  • Synthesis of information on polymyxin structure-activity relationships.

Main Results:

  • Polymyxins exhibit complex antibacterial mechanisms targeting bacterial membranes.
  • Bacteria develop tolerance through various mechanisms, including modifications to lipopolysaccharide.
  • Structural modifications offer potential for developing novel polymyxin derivatives.

Conclusions:

  • Understanding polymyxin mechanisms and resistance is crucial for combating MDR infections.
  • Development of new polymyxin derivatives is essential for future clinical applications.
  • Optimizing polymyxin clinical use can mitigate resistance development and preserve therapeutic efficacy.

More Related Videos

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes08:23

Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes

Published on: March 2, 2020

13.8K
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing08:19

Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing

Published on: July 7, 2020

11.6K

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
155
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.1K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
119
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
81
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
60
Antibiotic Selection00:57

Antibiotic Selection

Overview
62.4K